Abstract
Molecular surveillance of hematopoietic chimerism is an important part of the routine diagnostic program in patients after allogeneic stem cell transplantation. Chimerism testing permits early prediction and documentation of successful engraftment and facilitates early risk assessment of impending graft rejection. In patients transplanted for treatment of malignant hematologic disorders, monitoring of chimerism can provide an early indication of incipient disease relapse. The investigation of chimerism has therefore become an indispensable tool for the management of patients during the post-transplant period. Increasing use of reduced-intensity conditioning, which is associated with prolonged duration of mixed hematopoietic chimerism, has further increased the clinical importance of chimerism analysis. At present, the most commonly used technical approach to the investigation of chimerism is microsatellite analysis by polymerase chain reaction. The investigation of chimerism within specific leukocyte subsets isolated from peripheral blood or bone marrow samples by flow sorting- or magnetic bead-based techniques provides more specific information on processes underlying the dynamics of donor/recipient chimerism. Moreover, cell subset-specific analysis permits the assessment of impending complications at a significantly higher sensitivity, thus providing a basis for earlier treatment decisions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dubovsky J, Daxberger H, Fritsch G, Printz D, Peters C, Matthes S et al (1999) Kinetics of chimerism during the early post-transplant period in pediatric patients with malignant and non-malignant hematologic disorders: implications for timely detection of engraftment, graft failure and rejection. Leukemia 13:2060–2069
Pérez-Simón JA, Caballero D, Lopez-Pérez R, Mateos G, Canizo C, Vazquez L et al (2002) Chimerism and minimal residual disease monitoring after reduced intensity conditioning (RIC) allogeneic transplantation. Leukemia 16:1423–1431
Matthes-Martin S, Lion T, Haas OA, Frommlet F, Daxberger H, Konig M et al (2003) Lineage-specific chimaerism after stem cell transplantation in children following reduced intensity conditioning: potential predictive value of NK-cell chimaerism for late graft rejection. Leukemia 17:1934–1942
Lion T, Daxberger H, Dubovsky J, Filipcik P, Fritsch G, Printz D et al (2001) Analysis of chimerism within specific leukocyte subsets for detection of residual or recurrent leukemia in pediatric patients after allogeneic stem cell transplantation. Leukemia 15:307–310
Liesveld JL, Rothberg PG (2008) Mixed chimerism in SCT: conflict or peaceful coexistence? Bone Marrow Transplant 42:297–310
Lawler M, McCann SR, Marsh JC, Ljungman P, Hows J, Vandenberghe E, Severe Aplastic Anaemia Working Party of the European Blood and Marrow Transplant Group et al (2009) Serial chimerism analyses indicate that mixed haemopoietic chimerism influences the probability of graft rejection and disease recurrence following allogeneic stem cell transplantation (SCT) for severe aplastic anaemia (SAA): indication for routine assessment of chimerism post SCT for SAA. Br J Haematol 144:933–945
Breuer S, Preuner S, Fritsch G, Daxberger H, Koenig M, Poetschger U et al (2012) Early recipient chimerism testing in the T- and NK-cell lineages for risk assessment of graft rejection in pediatric patients undergoing allogeneic stem cell transplantation. Leukemia 26:509–519
Bader P, Kreyenberg H, Hoelle W, Dueckers G, Handgretinger R, Lang P et al (2004) Increasing mixed chimerism is an important prognostic factor for unfavorable outcome in children with acute lymphoblastic leukemia after allogeneic stem-cell transplantation: possible role for pre-emptive immunotherapy? J Clin Oncol 22:1696–1705
Bader P, Kreyenberg H, Hoelle W, Dueckers G, Kremens B, Dilloo D et al (2004) Increasing mixed chimerism defines a high-risk group of childhood acute myelogenous leukemia patients after allogeneic stem cell transplantation where pre-emptive immunotherapy may be effective. Bone Marrow Transplant 33:815–821
Chalandon Y, Vischer S, Helg C, Chapuis B, Roosnek E (2003) Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Geneva experience. Leukemia 17:228–231
Schraml E, Daxberger H, Watzinger F, Lion T (2003) Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Vienna experience. Leukemia 17:224–227
Kreyenberg H, Holle W, Mohrle S, Niethammer D, Bader P (2003) Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Tuebingen experience. Leukemia 17:237–240
Acquaviva C, Duval M, Mirebeau D, Bertin R, Cave H (2003) Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Paris-Robert Debre experience. Leukemia 17:241–246
Hancock JP, Goulden NJ, Oakhill A, Steward CG (2003) Quantitative analysis of chimerism after allogeneic bone marrow transplantation using immunomagnetic selection and fluorescent microsatellite PCR. Leukemia 17:247–251
Koehl U, Beck O, Esser R, Seifried E, Klingebiel T, Schwabe D, Seidl C (2003) Quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection: the Frankfurt experience. Leukemia 17:232–236
Maas F, Schaap N, Kolen S, Zoetbrood A, Buno I, Dolstra H et al (2003) Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia 17:621–629
Fredriksson M, Barbany G, Liljedahl U, Hermanson M, Kataja M, Syvänen AC (2004) Assessing hematopoietic chimerism after allogeneic stem cell transplantation by multiplexed SNP genotyping using microarrays and quantitative analysis of SNP alleles. Leukemia 18:255–266
Jimenez-Velasco A, Barrios M, Roman-Gomez J, Navarro G, Buno I, Castillejo JA et al (2005) Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms. Leukemia 19:336–343
Najfeld V, Burnett W, Vlachos A, Scigliano E, Isola L, Fruchtman S (1997) Interphase FISH analysis of sex-mismatched BMT utilizing dual color XY probes. Bone Marrow Transplant 19:829–834
Lion T (2003) Summary: reports on quantitative analysis of chimerism after allogeneic stem cell transplantation by PCR amplification of microsatellite markers and capillary electrophoresis with fluorescence detection. Leukemia 17:252–254
Watzinger F, Lion T, Steward C (2006) The RSD code: proposal for a nomenclature of allelic configurations in SRT-PCR-based chimerism testing after allogeneic stem cell transplantation. Leukemia 20:1448–1452
Thiede C, Bornhäuser U, Brendel C, Leo R, Daxberger H, Mohr B et al (2001) Sequential monitoring of chimerism and detection of minimal residual disease after allogeneic blood stem transplantation (BSCT) using multiplex PCR amplification of short tandem repeat-markers. Leukemia 15:293–302
Lion T, Watzinger F, Preuner S, Kreyenberg H, Tilanus M, de Weger R et al (2012) The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation. Leukemia 26:1821–1828
Thiede C, Prange-Krex G, Freiberg-Richter J, Bornhauser M, Ehninger G (2000) Buccal swabs but not mouthwash samples can be used to obtain pretransplant DNA fingerprints from recipients of allogeneic bone marrow transplants. Bone Marrow Transplant 25:575–577
Thiede C, Lion T (2001) Quantitative analysis of chimerism after allogeneic stem cell transplantation using multiplex PCR amplification of short tandem repeat markers and fluorescence detection. Leukemia 15:303–306
Moretti TR, Baumstark AL, Defenbaugh DA, Keys KM, Smerick JB, Budowle B (2001) Validation of short tandem repeats (STRs) for forensic usage: performance testing of fluorescent multiplex STR systems and analysis of authentic and simulated forensic samples. J Forensic Sci 46:647–660
Schraml E, Lion T (2003) Interference of dye-associated fluorescence signals with quantitative analysis of chimerism by capillary electrophoresis. Leukemia 17:221–223
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer Science+Business Media, New York
About this protocol
Cite this protocol
Preuner, S., Lion, T. (2014). Post-transplant Monitoring of Chimerism by Lineage-Specific Analysis. In: Beksaç, M. (eds) Bone Marrow and Stem Cell Transplantation. Methods in Molecular Biology, vol 1109. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4614-9437-9_14
Download citation
DOI: https://doi.org/10.1007/978-1-4614-9437-9_14
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4614-9436-2
Online ISBN: 978-1-4614-9437-9
eBook Packages: Springer Protocols